CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 

Cumulative Kempharm Inc's Total Debt to Equity for Trailing Twelve Months Period

KMPH's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

KMPH Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -28.8 % -24.05 % 44.21 % - -
Y / Y Total Debt Growth - - - - -
Total Debt to Equity for Trailing Twelve Months Period 0.06 0.03 - 0 0.25
Total Ranking # # # # 171 # 286
Seq. Equity Growth -5.48 % -18.33 % -4.42 % -3.51 % 0.82 %
Seq. Total Debt Growth 0 % - - - -


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite repayements of liabilities of 0% in III. Quarter, Total Debt to Equity for Trailing Twelve Months Period improved to 0.06, below Kempharm Inc's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry Kempharm Inc achieved lowest Total Debt to Equity for Trailing Twelve Months Period. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
KMPH Charts and Quotes
Total Debt to Equity KMPH in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.78 0.26 0
(Jun 30 2021)   (Dec 31 2021)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Mersana Therapeutics inc   0.16 
Roivant Sciences Ltd   0.16 
Prophase Labs Inc   0.15 
Cerevel Therapeutics Holdings Inc   0.15 
9 Meters Biopharma Inc   0.15 
Spectrum Pharmaceuticals Inc   0.15 
Chemocentryx Inc.  0.14 
Qilian International Holding Group Limited  0.14 
Adial Pharmaceuticals Inc   0.13 
Trevena inc   0.13 
Capricor Therapeutics inc   0.13 
Frequency Therapeutics Inc   0.13 
Regulus Therapeutics Inc.  0.13 
Rvl Pharmaceuticals Plc  0.13 
Beigene Ltd   0.13 
Lexicon Pharmaceuticals Inc   0.13 
Oncotelic Therapeutics Inc   0.13 
Affimed N v   0.13 
F star Therapeutics Inc   0.12 
Opko Health Inc   0.12 
Xilio Therapeutics inc   0.12 
Cingulate Inc   0.12 
Centessa Pharmaceuticals Plc  0.12 
Celsion Corporation  0.11 
89bio Inc   0.11 
Bicycle Therapeutics Plc  0.11 
Regeneron Pharmaceuticals Inc   0.10 
Pds Biotechnology Corp  0.10 
Inventiva S a   0.10 
Opiant Pharmaceuticals Inc   0.10 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GAHC's Profile

Stock Price

GAHC's Financials

Business Description

Fundamentals

Charts & Quotes

GAHC's News

Suppliers

GAHC's Competitors

Customers & Markets

Economic Indicators

GAHC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071